EPCAM and metastatic neoplasm: To model a multi-metastatic disease, five cancer cell lines were mixed with different phenotypes (EpCAM(+), EpCAM(-), small-sized, and large-sized CTCs) and the recovery rate was confirmed to emphasize the usefulness of CCM-CTCD even in multi-metastatic cancer patients.